GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Operating Expenses | 1,538 | 822 | 2,530 | 2,121 | 3,901 |
| Operating Income | -1,538 | -822 | -2,530 | -2,121 | -3,901 |
| Interest Expense | 3,520 | 1,774 | 1,536 | 1,599 | 1,646 |
| Other Income | 0 | -11,498 | 436 | 5,263 | 31,496 |
| Pre-tax Income | -5,058 | -14,094 | -3,630 | 1,543 | 25,949 |
| Net Income Continuous | -5,058 | -14,094 | -3,630 | 1,543 | 25,949 |
| Net Income | $-5,058 | $-14,094 | $-3,630 | $1,543 | $25,949 |
| EPS Basic Total Ops | -13,462.44 | 81,468.32 | -20,249.84 | 19.84 | 1.49 |
| EPS Basic Continuous Ops | -13,464.87 | 81,370.34 | -20,151.03 | 19.84 | 1.49 |
| EPS Diluted Total Ops | -13,462.44 | 81,469.95 | -20,249.84 | 18.22 | 1.49 |
| EPS Diluted Continuous Ops | -13,464.87 | 81,371.95 | -20,151.03 | 18.22 | 1.49 |
| EBITDA(a) | $-723 | $450 | $-1,876 | $-1,956 | $-3,094 |